{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:04:59Z","timestamp":1789502699545,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13304-022-01399-y","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T12:04:18Z","timestamp":1668254658000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience"],"prefix":"10.1007","volume":"75","author":[{"given":"Niccol\u00f2","family":"Allievi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Montori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fugazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Coccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Merelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Campanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lucianetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-3754","authenticated-orcid":false,"given":"Stefano","family":"Magnone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"1399_CR1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2013.850740","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, Bernards N, Van GYR, Jacobs EM, Lemmens VE, De HIH (2014) Chemotherapy as palliative treatment for peritoneal carcinomatosis of gastric origin. Acta Oncol. https:\/\/doi.org\/10.3109\/0284186X.2013.850740","journal-title":"Acta Oncol"},{"key":"1399_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0517-9","author":"B Badgwell","year":"2017","unstructured":"Badgwell B, Das P, Ajani J (2017) Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-017-0517-9","journal-title":"J Hematol Oncol"},{"key":"1399_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"628","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, VanGestel YR, Van Ramshorst B et al (2014) Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 628:622\u2013628. https:\/\/doi.org\/10.1002\/ijc.28373","journal-title":"Int J Cancer"},{"key":"1399_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"1","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies results of the EVOCAPE 1 multicentric prospective study. Cancer 1:358\u2013363","journal-title":"Cancer"},{"issue":"2","key":"1399_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/01.sla.0000197382.43208.a5","volume":"243","author":"AI Sarela","year":"2006","unstructured":"Sarela AI, Miner TJ, Karpeh MS, Coit DG, Jaques DP, Brennan MF (2006) Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243(2):189\u2013195. https:\/\/doi.org\/10.1097\/01.sla.0000197382.43208.a5","journal-title":"Ann Surg"},{"issue":"5","key":"1399_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4251\/wjgo.v12.i5.569","volume":"12","author":"R Yarema","year":"2020","unstructured":"Yarema R, Ohorchak M, Hyrya P (2020) Gastric cancer with peritoneal metastases: efficiency of standard treatment methods. WJGO. 12(5):569\u2013581","journal-title":"WJGO."},{"key":"1399_CR7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5409-7","author":"N Ikoma","year":"2016","unstructured":"Ikoma N, Blum M, Chiang Y et al (2016) Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-016-5409-7","journal-title":"Ann Surg Oncol"},{"issue":"March","key":"1399_CR8","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","volume":"24","author":"N Ikoma","year":"2017","unstructured":"Ikoma N, Chen H, Wang X et al (2017) Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol 24(March):2679\u20132687. https:\/\/doi.org\/10.1245\/s10434-017-5838-y","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1399_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","volume":"219","author":"G Spolverato","year":"2014","unstructured":"Spolverato G, Ejaz A, Kim Y et al (2014) Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg 219(4):664\u2013675. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.03.062","journal-title":"J Am Coll Surg"},{"issue":"3","key":"1399_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1055-3207(03)00035-8","volume":"12","author":"Y Yonemura","year":"2003","unstructured":"Yonemura Y, Bandou E, Kazuo K et al (2003) Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am 12(3):635\u2013648","journal-title":"Surg Oncol Clin N Am"},{"key":"1399_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1245\/s10434-009-0764-2","volume":"2010","author":"Y Homma","year":"2009","unstructured":"Homma Y, Ushida S, Yamada M, Kobayashi H (2009) Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients. Ann Surg Oncol 2010:455\u2013460. https:\/\/doi.org\/10.1245\/s10434-009-0764-2","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1399_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","volume":"40","author":"F Coccolini","year":"2014","unstructured":"Coccolini F, Cotte E, Glehen O et al (2014) Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol 40(1):12\u201326. https:\/\/doi.org\/10.1016\/j.ejso.2013.10.019","journal-title":"Eur J Surg Oncol"},{"key":"1399_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519882545","author":"Y Liu","year":"2019","unstructured":"Liu Y, Du Y, Chen B (2019) Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials. J Int Med Res. https:\/\/doi.org\/10.1177\/0300060519882545","journal-title":"J Int Med Res"},{"key":"1399_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","volume":"42","author":"Y Yonemura","year":"2016","unstructured":"Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O (2016) A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. EJSO 42:1123\u20131131. https:\/\/doi.org\/10.1016\/j.ejso.2016.03.016","journal-title":"EJSO"},{"issue":"9","key":"1399_CR15","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C et al (2010) Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9):2370\u20132377. https:\/\/doi.org\/10.1245\/s10434-010-1039-7","journal-title":"Ann Surg Oncol"},{"key":"1399_CR16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"2011","author":"X Yang","year":"2010","unstructured":"Yang X, Huang C, Suo T, Mei L, Yang G (2010) cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Annu Surg Oncol 2011:1575\u20131581. https:\/\/doi.org\/10.1245\/s10434-011-1631-5","journal-title":"Annu Surg Oncol"},{"issue":"3","key":"1399_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633.Impact","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, Beane JD, Seth M (2014) Impact of maximal cytoreductive surgery plus regional heated intra-peritoneal chemotherapy (HIPEC) on outcomes of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA Trial. J Surg Oncol 110(3):275\u2013284. https:\/\/doi.org\/10.1002\/jso.23633.Impact","journal-title":"J Surg Oncol"},{"issue":"23","key":"1399_CR18","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V et al (2019) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol 37(23):2028\u20132040. https:\/\/doi.org\/10.1200\/JCO.18.01688","journal-title":"J Clin Oncol"},{"issue":"3","key":"1399_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.21037\/jgo.2017.03.11","volume":"8","author":"P Fugazzola","year":"2017","unstructured":"Fugazzola P, Coccolini F, Montori G et al (2017) Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis. J Gastrointest Oncol 8(3):572\u2013582. https:\/\/doi.org\/10.21037\/jgo.2017.03.11","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"1399_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","volume":"28","author":"B Badgwell","year":"2021","unstructured":"Badgwell B, Ikoma N, Murphy MB, Wang X (2021) A phase II trial of cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and carcinomatosis or positive cytology. Ann Surg Oncol 28(1):258\u2013264. https:\/\/doi.org\/10.1245\/s10434-020-08739-5","journal-title":"Ann Surg Oncol"},{"issue":"August","key":"1399_CR21","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W et al (2016) clinical practice guidelines Gastric cancer: ESMO Clinical Practice Guidelines for clinical practice guidelines. ESMO Updat Clin Pract Guidel 27(August):v38\u2013v49. https:\/\/doi.org\/10.1093\/annonc\/mdw350","journal-title":"ESMO Updat Clin Pract Guidel"},{"key":"1399_CR22","unstructured":"Clinical N, Guidelines P, Guidelines N. Gastric Cancer. Published online 2021."},{"key":"1399_CR23","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1245\/s10434-020-08320-0","volume":"2020","author":"Consensus C, Group W","year":"2019","unstructured":"Consensus C, Group W (2019) The Chicago consensus on peritoneal surface malignancies: management of gastric metastases. Annu Surg Oncol 2020:1768\u20131773. https:\/\/doi.org\/10.1245\/s10434-020-08320-0","journal-title":"Annu Surg Oncol"},{"key":"1399_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejso.2006.03.002","volume":"32","author":"FN Gilly","year":"2006","unstructured":"Gilly FN, Cotte E, Brigand C, Monneuse O (2006) Quantitative prognostic indices in peritoneal carcinomatosis. EJSO 32:597\u2013601. https:\/\/doi.org\/10.1016\/j.ejso.2006.03.002","journal-title":"EJSO"},{"key":"1399_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker P (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374","journal-title":"Cancer Treat Res"},{"issue":"2","key":"1399_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P (2004) Classification of surgical complications 240(2):205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Classification of surgical complications"},{"issue":"1","key":"1399_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-0-387-48993-3_15","volume":"221","author":"PH Sugarbaker","year":"2007","unstructured":"Sugarbaker PH (2007) Peritonectomy procedures. Perit Carcinomatosis A Multidiscip Approach 221(1):247\u2013264. https:\/\/doi.org\/10.1007\/978-0-387-48993-3_15","journal-title":"Perit Carcinomatosis A Multidiscip Approach"},{"issue":"12","key":"1399_CR28","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1093\/annonc\/mdt401","volume":"24","author":"N Bernards","year":"2013","unstructured":"Bernards N, Creemers GJ, Nieuwenhuijzen GAP, Bosscha K, Pruijt JFM, Lemmens VEPP (2013) No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol 24(12):3056\u20133060. https:\/\/doi.org\/10.1093\/annonc\/mdt401","journal-title":"Ann Oncol"},{"issue":"10","key":"1399_CR29","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1245\/s10434-007-9487-4","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Mbbs M, Black D et al (2007) A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Annu Surg Oncol 14(10):2702\u20132713. https:\/\/doi.org\/10.1245\/s10434-007-9487-4","journal-title":"Annu Surg Oncol"},{"issue":"1","key":"1399_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-183","volume":"14","author":"O Glehen","year":"2014","unstructured":"Glehen O, Passot G, Villeneuve L et al (2014) GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 14(1):1\u201310. https:\/\/doi.org\/10.1186\/1471-2407-14-183","journal-title":"BMC Cancer"},{"issue":"8","key":"1399_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jcma.2013.04.004","volume":"76","author":"L Kang","year":"2013","unstructured":"Kang L, Mok K, Liu S et al (2013) Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. J Chinese Med Assoc 76(8):425\u2013431. https:\/\/doi.org\/10.1016\/j.jcma.2013.04.004","journal-title":"J Chinese Med Assoc"},{"issue":"11","key":"1399_CR32","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ejso.2007.12.003","volume":"34","author":"S Scaringi","year":"2021","unstructured":"Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B (2021) Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol 34(11):1246\u20131252. https:\/\/doi.org\/10.1016\/j.ejso.2007.12.003","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"1399_CR33","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s10120-019-00969-1","volume":"22","author":"B Rau","year":"2019","unstructured":"Rau B, Brandl A, Thuss P et al (2019) The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis. Gastric Cancer 22(6):1226\u20131237. https:\/\/doi.org\/10.1007\/s10120-019-00969-1","journal-title":"Gastric Cancer"},{"key":"1399_CR34","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","volume":"26","author":"I Manzanedo","year":"2019","unstructured":"Manzanedo I, Pereira F, Caro CR, Gutie A, Mart\u0131 G (2019) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish group of peritoneal oncologic surgery (GECOP). Ann Surg Oncol 26:2615\u20132621. https:\/\/doi.org\/10.1245\/s10434-019-07450-4","journal-title":"Ann Surg Oncol"},{"key":"1399_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5640-2","volume":"19","author":"WJ Koemans","year":"2019","unstructured":"Koemans WJ, Van Der KRT, Boot H et al (2019) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer 19:1\u20138","journal-title":"BMC Cancer"},{"issue":"6","key":"1399_CR36","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.amjsurg.2012.06.009","volume":"205","author":"EI Benizri","year":"2013","unstructured":"Benizri EI, Ph D, Bereder J, Rahili A, Bernard J, Benchimol D (2013) Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer. Am J Surg 205(6):668\u2013673. https:\/\/doi.org\/10.1016\/j.amjsurg.2012.06.009","journal-title":"Am J Surg"},{"key":"1399_CR37","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08842-7","author":"MG White","year":"2020","unstructured":"White MG, Kothari A, Ikoma N, Murphy MB (2020) Factors associated with resection and survival after laparoscopic HIPEC for peritoneal gastric cancer metastasis. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-020-08842-7","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"1399_CR38","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1245\/s10434-019-07638-8","volume":"26","author":"AP Stark","year":"2019","unstructured":"Stark AP, Ikoma N, Chiang YJ et al (2019) Characteristics and survival of gastric cancer patients with pathologic complete response to preoperative therapy. Ann Surg Oncol 26(11):3602\u20133610. https:\/\/doi.org\/10.1245\/s10434-019-07638-8","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1399_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejso.2020.10.006","volume":"47","author":"A Brandl","year":"2021","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B (2021) Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi- institutional cohort from PSOGI. Eur J Surg Oncol 47(1):172\u2013180. https:\/\/doi.org\/10.1016\/j.ejso.2020.10.006","journal-title":"Eur J Surg Oncol"},{"key":"1399_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-318070","author":"R Wang","year":"2020","unstructured":"Wang R, Song S, Harada K et al (2020) Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2018-318070","journal-title":"Gut"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-022-01399-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-022-01399-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-022-01399-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T04:45:07Z","timestamp":1673412307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-022-01399-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1399"],"URL":"https:\/\/doi.org\/10.1007\/s13304-022-01399-y","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted under the WMA declaration of helsinki and is compliant with Ethical Standards, Research involving human participants and\/or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Due to the retrospective nature, consent for participation in the study was waived, and no direct referral to patient data is evident.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}